Sunday, June 28, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 568 of 1,261
  1. US 9963700

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  2. US 9963515

    Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted May 8, 2018 · Expires May 3, 2038

    granted
  3. US 9962319

    One-component-type dentinal tubule sealant

    KURARAY NORITAKE DENTAL INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  4. US 9963699

    Methods for modulating C9ORF72 expression

    The Regents of the University of California · Granted May 8, 2018 · Expires May 3, 2038

    granted
  5. US 9963443

    Radiolabeled compounds

    Takeda Pharmaceutical Company Limited · Granted May 8, 2018 · Expires May 3, 2038

    granted
  6. US 9963450

    A3 adenosine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 8, 2018 · Expires May 3, 2038

    granted
  7. US 9962390

    Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration

    KOREA UNITED PHARM. INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  8. US 9962449

    MultiLigand agent for drug delivery

    ARCTURUS THERAPEUTICS, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  9. US 9962432

    Minimizing intestinal dysfunction

    The Regents of the University of California · Granted May 8, 2018 · Expires May 3, 2038

    granted
  10. US 9962395

    Compositions and methods for maintaining cognitive function

    The Regents of the University of California · Granted May 8, 2018 · Expires May 3, 2038

    granted
  11. US 9962379

    Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

    United States Government as represented by the Department of Veterans Affairs · Granted May 8, 2018 · Expires May 3, 2038

    granted
  12. US 9962370

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted
  13. US 9963715

    Methods and compositions for treatment of a genetic condition

    Sangamo Therapeutics, Inc. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  14. US 9962368

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted May 8, 2018 · Expires May 3, 2038

    granted
  15. US 9962363

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted May 8, 2018 · Expires May 3, 2038

    granted
  16. US 9963504

    Anti-CXCL13 antibodies and methods of using the same

    VACCINEX, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  17. US 9956278

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  18. US 9957501

    Nuclease-mediated regulation of gene expression

    Sangamo Therapeutics, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  19. US 9957507

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  20. US 9957504

    Compositions and methods for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  21. US 9957486

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  22. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Julius-Maximilians-Universitat Wurzburg · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  23. US 9957324

    Anti-FLT-1 antibodies in treating duchenne muscular dystrophy

    Regents of the University of Minnesota · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  24. US 9957526

    Delivery methods and compositions for nuclease-mediated genome engineering

    Sangamo Therapeutics, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.